Class IIOngoingVoluntary: Firm initiated
Mondelez Global Llc: food recall H-0325-2025
Mondelez Global Llc of East Hanover, NJ recalled Ritz Cracker Sandwiches, Variety 20 count variety Pack, (20- Packs of 10 Cheese 1.35 oz Packs and 10 Peanut Butter… Reason: Undeclared allergens (Peanut) due to mispackaging. The FDA listed it as Class II in its Enforcement Report dated Jul 30, 2025; distribution: Alaska, Alabama, Arkansas, Arizona, California, Colorado, Connecticut, District of Columbia, Delaware, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, West Virginia, Wyoming.
Record status as published: Ongoing. openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Ritz Cracker Sandwiches, Variety 20 count variety Pack, (20- Packs of 10 Cheese 1.35 oz Packs and 10 Peanut Butter 1.38 oz Packs) Net Wt. 27.3 oz (20-1.38 oz packet of cracker sandwiches inside cartons of varying sizes). 20-27.3 OZ (Case: 6 - 27.3 Oz Cartons in master carton. UPC 0 44000 08095 2
- Product quantity
- 13,872 cases
- Reason for recall
- Undeclared allergens (Peanut) due to mispackaging
- Codes, lots and dates on the package
- 2 NOV 25 - 9 NOV 25
- Distribution pattern
- The recalled product was distributed to the following states: AK,AL,AR,AZ,CA,CO,CT,DC,DE,FL,GA,HI,IA,ID,IL,IN,KS,KY,LA,MA,MD,ME,MI,MN,MO,MS,MT,NC,ND,NE,NH,NJ,NM,NV,NY,OH,OK,OR,PA,RI,SC,TN,TX,UT,VA,WA,WI,WV,WY
- Recalling firm
- Mondelez Global Llc, East Hanover, NJ
- Classification
- Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Jul 8, 2025 |
| Classified by the FDA | Jul 22, 2025 |
| Published in the Enforcement Report | Jul 30, 2025 |
Other products in the same recall event
The FDA groups related products under one recall event (event 97238).
- H-0326-2025 — Ritz Peanut Butter Cracker Sandwiches, Net Wt. 11.4 oz, 8 count (8x1.38 oz 6 pack of cracker sandwiches inside carton. 14X8-Case: 14 - 11.04 Oz Cartons in master carton. UPC 0 44000 88210 5
- H-0324-2025 — Ritz Peanut Butter Cracker Sandwiches, Net Wt. 55.2 oz, 40 count (40x1.38 oz 6 pack of cracker sandwiches inside carton. 40 - 55.2oz Cartons in master carton. UPC 0 44000 07819 5
- H-0323-2025 — Ritz Peanut Butter Cracker Sandwiches, Net Wt.27.6 oz, 20 count (20x1.38 oz) 6- pack of cracker sandwiches inside cartons. And 6x20(6 - 27.6 oz Cartons) in master carton. UPC 1 00 44000 07584 2
Other recalls by Mondelez Global Llc
- H-0667-2026 · Apr 29, 2026 · Class II — Hard corn starch lumps were found in the product
- H-0329-2026 · Dec 31, 2025 · Class II — Undeclared allergens (Peanut) due to mispackaging
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0325-2025 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.